Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study

INTRODUCTION: While the psychiatric benefits of ketamine have been verified through clinical trials, there is limited information about ketamine augmentation in patients with treatment‐resistant bipolar depression (TRBPD). Hence, in the present study, we investigate the therapeutic efficacy and func...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Chuanjun, Ji, Feng, Tian, Hongjun, Wang, Lina, Jia, Feng, Jiang, Deguo, Chen, Ce, Zhou, Chunhua, Lin, Xiaodong, Zhu, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428494/
https://www.ncbi.nlm.nih.gov/pubmed/32621379
http://dx.doi.org/10.1002/brb3.1674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428494/
https://www.ncbi.nlm.nih.gov/pubmed/32621379
http://dx.doi.org/10.1002/brb3.1674

Ejemplares similares